Ranibizumab for
diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
A prospective study that compared the effects of triamcinolone acetonide and bevacizumab injections on choroidal thickness in
diabetic macular edema showed a significant decrease in subfoveal choroidal thickness from 24 hours to 12 weeks with triamcinolone acetonide (25).
A total of 55 patients of
diabetic macular edema received IVB during the study period.
Kwon, "Optical coherence tomography-guided selective focal laser photocoagulation: a novel laser protocol for
diabetic macular edema," Graefe's Archive for Clinical and Experimental Ophthalmology, vol.
Updike et al., "Relationship between optical coherence tomography retinal parameters and visual acuity in
diabetic macular edema," Ophthalmology, vol.
Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for
diabetic macular edema. ETDRS number 1.
Optical coherence tomographic assessment of
diabetic macular edema: comparison with fluorescein angiographic and clinical findings.
Diabetic macular edema is a special form of diabetic retinopathy, a highly specific microvascular complication of diabetes on the eyes.
Qin, "Intravitreal ranibizumab for
diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results," Ophthalmology, vol.
Intravitreal OZURDEX: Is it "The Magic Potion" for
Diabetic Macular Edema — Dr Nishikant Borse
This report provides comprehensive information on the therapeutic development for
Diabetic Macular Edema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.